List of Tables
Summary Table: Global Market for Diabetes Therapeutics and Diagnostics, by Segment, Through 2028
Table 1: Key Facts and Latest Data for Diabetes Globally, 2021 and 2045
Table 2: Global Diabetes Estimates and Projections, 2019-2045
Table 3: Global Prevalence of Diabetes, by Type, Through 2040
Table 4: Global Diabetes Cases, by Country, 2000-2045
Table 5: Age-Adjusted Comparative Prevalence of Diabetes, by Region, 2010-2040
Table 6: First-Time Generic Drug Approvals for Type 2 Diabetes, October 2022-2021
Table 7: Global Revenues of Leading Antidiabetic Pharmaceutical Companies, 2022
Table 8: Comparison of Insulin Action of Leading Insulin Products
Table 9: Comparison of GLP-1 Analogs
Table 10: U.S. Patent Expiry Dates for the World’s Top Selling Diabetes Drugs
Table 11: Novo Nordisk’s Current R&D Pipeline
Table 12: Lilly's Current R&D Pipeline
Table 13: AstraZeneca's Current R&D Pipeline
Table 14: Terminology Used to Describe Generic Biopharmaceuticals, by Country/Region
Table 15: Global Market for Diabetes Therapeutics, by Region, Through 2028
Table 16: Global Market for Diabetes Therapeutics, by Type, Through 2028
Table 17: Global Market for Injectable Diabetes Therapies, by Region, Through 2028
Table 18: Global Market for Oral Antidiabetic Drugs, by Region, Through 2028
Table 19: Global Market for Injectable Diabetes Therapies, by Type, Through 2028
Table 20: Global Market for Diabetic GLP-1 Therapy, by Region, Through 2028
Table 21: Global Market for Insulin Therapy, by Region, Through 2028
Table 22: Leading Blood Glucose Manufacturers and Blood Glucose Products
Table 23: Leading Lancet and Lancet Device Manufacturers and Products
Table 24: Comparison of Abbott Freestyle Blood Glucose Monitoring System Readers
Table 25: Global Market for Diabetes Monitoring Devices and Accessories, by Type, Through 2028
Table 26: Global Market for Diabetes Monitoring Devices and Accessories, by Region, Through 2028
Table 27: Global Market for Blood Glucose Test Strips, by Region, Through 2028
Table 28: Globa Market for Blood Glucose Meters, by Region, Through 2028
Table 29: Global Market for Lancets and Lancet Devices, by Region, Through 2028
Table 30: Global Market for Continuous Glucose Monitoring Systems, by Region, Through 2028
Table 31: Leading Insulin Syringes Manufacturers and Insulin Syringe Products
Table 32: Commercially Available Insulin Injector Pens
Table 33: Leading Insulin Jet Injectors Manufacturers and Products
Table 34: Leading External Insulin Pump Manufacturers and Products
Table 35: Key Features of Current Leading Insulin Pump Systems
Table 36: Global Market for Diabetes Delivery Devices, by Type, Through 2028
Table 37: Global Market for Diabetes Delivery Devices, by Region, Through 2028
Table 38: Global Market for Insulin Syringes, by Region, Through 2028
Table 39: Global Market for Insulin Pens and Needles (Reusable and Disposable), by Region, Through 2028
Table 40: Global Market for Insulin Jet Injectors, by Region, Through 2028
Table 41: Global Market for External Insulin Pumps, by Region, Through 2028
Table 42: Global Market for Implantable Insulin Pumps, by Region, Through 2028
Table 43: Global Market for Insulin Inhalers, by Region, Through 2028
Table 44: Global Market for Insulin Patches, by Region, Through 2028
Table 45: Global Market for Diabetes Therapeutics and Diagnostics, by End User, Through 2028
Table 46: Global Market for Diabetes Therapeutic and Diagnostics in Hospitals and Clinics, by Region, Through 2028
Table 47: Global Market for Diabetes Therapeutic and Diagnostics in Diagnostic Centers, by Region, Through 2028
Table 48: Global Market for Diabetes Therapeutics and Diagnostics in Home Care Organizations, by Region, Through 2028
Table 49: Global Market for Diabetes Therapeutics and Diagnostics, by Region, Through 2028
Table 50: North American Market for Diabetes Therapeutics and Diagnostics, by Country, Through 2028
Table 51: North American Market for Diabetes Therapeutics and Diagnostics, by Segment Type, Through 2028
Table 52: North American Market for Diabetes Therapeutics, by Type, Through 2028
Table 53: North American Market for Injectable Therapies, by Type, Through 2028
Table 54: North American Market for Diabetes Monitoring Devices and Accessories, by Type, Through 2028
Table 55: North American Market for Diabetes Delivery Devices, by Type, Through 2028
Table 56: North American Market for Diabetes Therapeutics and Diagnostics, by End User, Through 2028
Table 57: U.S. Market for Diabetes Therapeutics and Diagnostics, by Segment, Through 2028
Table 58: U.S. Market for Diabetes Therapeutics, by Type, Through 2028
Table 59: U.S. Market for Injectable Therapeutics, by Type, Through 2028
Table 60: U.S. Market for Diabetes Monitoring Devices and Accessories, by Type, Through 2028
Table 61: U.S. Market for Diabetes Delivery Devices, by Type, Through 2028
Table 62: U.S. Market for Diabetes Therapeutics and Diagnostics, by End User, Through 2028
Table 63: Canadian Market for Diabetes Therapeutics and Diagnostics, by Segment, Through 2028
Table 64: Canadian Market for Diabetes Therapeutics, by Type, Through 2028
Table 65: Canadian Market for Injectable Therapeutics, by Type, Through 2028
Table 66: Canadian Market for Diabetes Monitoring Devices and Accessories, by Type, Through 2028
Table 67: Canadian Market for Diabetes Delivery Devices, by Type, Through 2028
Table 68: Canadian Market for Diabetes Therapeutics and Diagnostics, by End User, Through 2028
Table 69: European Market for Diabetes Therapeutics and Diagnostics, by Country, Through 2028
Table 70: European Market for Diabetes Therapeutics and Diagnostics, by Segment, Through 2028
Table 71: European Market for Diabetes Therapeutics, by Type, Through 2028
Table 72: European Market for Injectable Therapeutics, by Type, Through 2028
Table 73: European Market for Diabetes Monitoring Devices and Accessories, by Type, Through 2028
Table 74: European Market for Diabetes Delivery Devices, by Type, Through 2028
Table 75: European Market for Diabetes Therapeutics and Diagnostics, by End User, Through 2028
Table 76: German Market for Diabetes Therapeutics and Diagnostics, by Segment, Through 2028
Table 77: German Market for Diabetes Therapeutics, by Type, Through 2028
Table 78: German Market for Injectable Therapeutics, by Type, Through 2028
Table 79: German Market for Diabetes Monitoring Devices and Accessories, by Type, Through 2028
Table 80: German Market for Diabetes Delivery Devices, by Type, Through 2028
Table 81: German Market for Diabetes Therapeutics and Diagnostics, by End User, Through 2028
Table 82: U.K. Market for Diabetes Therapeutics and Diagnostics, by Segment, Through 2028
Table 83: U.K. Market for Diabetes Therapeutics, by Type, Through 2028
Table 84: U.K. Market for Injectable Therapeutics, by Type, Through 2028
Table 85: U.K. Market for Diabetes Monitoring Device and Accessories, by Type, Through 2028
Table 86: U.K. Market for Diabetes Delivery Devices, by Type, Through 2028
Table 87: UK Market for Diabetes Therapeutics and Diagnostics, by End User, Through 2028
Table 88: French Market for Diabetes Therapeutics and Diagnostics, by Segment, Through 2028
Table 89: French Market for Diabetes Therapeutics, by Type, Through 2028
Table 90: French Market for Injectable Therapeutics, by Type, Through 2028
Table 91: French Market for Diabetes Monitoring Devices and Accessories, by Type, Through 2028
Table 92: French Market for Diabetes Delivery Devices, by Type, Through 2028
Table 93: French Market for Diabetes Therapeutics and Diagnostics, by End User, Through 2028
Table 94: Spanish Market for Diabetes Therapeutics and Diagnostics, by Segment, Through 2028
Table 95: Spanish Market for Diabetes Therapeutics, by Type, Through 2028
Table 96: Spanish Market for Injectable Therapeutics, by Type, Through 2028
Table 97: Spanish Market for Diabetes Monitoring Devices and Accessories, by Type, Through 2028
Table 98: Spanish Market for Diabetes Delivery Devices, by Type, Through 2028
Table 99: Spanish Market for Diabetes Therapeutics and Diagnostics, by End User, Through 2028
Table 100: Italian Market for Diabetes Therapeutics and Diagnostics, by Segment, Through 2028
Table 101: Italian Market for Diabetes Therapeutics, by Type, Through 2028
Table 102: Italian Market for Injectable Therapeutics, by Type, Through 2028
Table 103: Italian Market for Diabetes Monitoring Devices and Accessories, by Type, Through 2028
Table 104: Italian Market for Diabetes Delivery Devices, by Type, Through 2028
Table 105: Italian Market for Diabetes Therapeutics and Diagnostics, by End User, Through 2028
Table 106: Rest of European Market for Diabetes Therapeutics and Diagnostics, by Segment, Through 2028
Table 107: Rest of European Market for Diabetes Therapeutics, by Type, Through 2028
Table 108: Rest of European Market for Injectable Therapeutics, by Type, Through 2028
Table 109: Rest of European Market for Diabetes Monitoring Devices and Accessories, by Type, Through 2028
Table 110: Rest of European Market for Diabetes Delivery Devices, by Type, Through 2028
Table 111: Rest of European Market for Diabetes Therapeutics and Diagnostics, by End User, Through 2028
Table 112: Asia-Pacific Market for Diabetes Therapeutics and Diagnostics, by Country, Through 2028
Table 113: Asia-Pacific Market for Diabetes Therapeutics and Diagnostics, by Segment, Through 2028
Table 114: Asia-Pacific Market for Diabetes Therapeutics, by Type, Through 2028
Table 115: Asia-Pacific Market for Injectable Therapeutics, by Type, Through 2028
Table 116: Asia-Pacific Market for Diabetes Monitoring Devices and Accessories, by Type, Through 2028
Table 117: Asia-Pacific Market for Diabetes Delivery Devices, by Type, Through 2028
Table 118: Asia-Pacific Market for Diabetes Therapeutics and Diagnostics, by End User, Through 2028
Table 119: Major Chinese Pharmaceutical Companies Developing Antidiabetic Medicines, by Type
Table 120: Chinese Market for Diabetes Therapeutics and Diagnostics, by Segment, Through 2028
Table 121: Chinese Market for Diabetes Therapeutics, by Type, Through 2028
Table 122: Chinese Market for Injectable Therapeutics, by Type, Through 2028
Table 123: Chinese Market for Diabetes Monitoring Devices and Accessories, by Type, Through 2028
Table 124: Chinese Market for Diabetes Delivery Devices, by Type, Through 2028
Table 125: Chinese Market for Diabetes Therapeutics and Diagnostics, by End User,
Table 126: Indian Market for Diabetes Therapeutics and Diagnostics, by Segment, Through 2028
Table 127: Indian Market for Diabetes Therapeutics, by Type, Through 2028
Table 128: Indian Market for Injectable Therapeutics, by Type, Through 2028
Table 129: Indian Market for Diabetes Monitoring Devices and Accessories, by Type, Through 2028
Table 130: Indian Market for Diabetes Delivery Devices, by Type, Through 2028
Table 131: Indian Market for Diabetes Therapeutics and Diagnostics, by End User, Through 2028
Table 132: Japanese Market for Diabetes Therapeutics and Diagnostics, by Segment, Through 2028
Table 133: Japanese Market for Diabetes Therapeutics, by Type, Through 2028
Table 134: Japanese Market for Injectable Therapeutics, by Type, Through 2028
Table 135: Japanese Market for Diabetes Monitoring Devices and Accessories, by Type, Through 2028
Table 136: Japanese Market for Diabetes Delivery Devices, by Type, Through 2028
Table 137: Japanese Market for Diabetes Therapeutics and Diagnostics, by End User, Through 2028
Table 138: Australian Market for Diabetes Therapeutics and Diagnostics, by Segment, Through 2028
Table 139: Australian Market for Diabetes Therapeutics, by Type, Through 2028
Table 140: Australian Market for Injectable Therapeutics, by Type, Through 2028
Table 141: Australian Market for Diabetes Monitoring Devices and Accessories, by Type, Through 2028
Table 142: Australian Market for Diabetes Delivery Devices, by Type, Through 2028
Table 143: Australian Market for Diabetes Therapeutics and Diagnostics, by End User, Through 2028
Table 144: Rest of Asia-Pacific Market for Diabetes Therapeutics and Diagnostics, by Segment, Through 2028
Table 145: Rest of Asia-Pacific Market for Diabetes Therapeutics, by Type, Through 2028
Table 146: Rest of Asia-Pacific Market for Injectable Therapeutics, by Type, Through 2028
Table 147: Rest of Asia-Pacific Market for Diabetes Monitoring Devices and Accessories, by Type, Through 2028
Table 148: Rest of Asia-Pacific Market for Diabetes Delivery Devices, by Region, Through 2028
Table 149: Rest of Asia-Pacific Market for Diabetes Therapeutics and Diagnostics, by End User, Through 2028
Table 150: Rest of the World Market for Diabetes Therapeutics and Diagnostics, by Segment, Through 2028
Table 151: Rest of the World Market for Diabetes Therapeutics, by Type, Through 2028
Table 152: Rest of the World Market for Injectable Therapeutics, by Type, Through 2028
Table 153: Rest of the World Market for Diabetes Monitoring Devices and Accessories, by Type, Through 2028
Table 154: Rest of the World Market for Diabetes Delivery Devices, by Type, Through 2028
Table 155: Rest of the World Market for Diabetes Therapeutics and Diagnostics, by End User, Through 2028
Table 156: ESG Performance Analysis of the Market for Diabetes Therapeutics and Diagnostics
Table 157: Social Performance of the Market for Diabetes Therapeutics and Diagnostics
Table 158: Governance Performance of the Market for Diabetes Therapeutics and Diagnostics
Table 159: Selected Artificial Pancreas in Clinical Trials, as of 2023
Table 160: Mergers and Acquisitions in the Global Market for Diabetes Therapeutics and Diagnostics, January 2018 to June 2023
Table 161: Top 10 Deals in the Market for Diabetes Therapeutics and Diagnostics, by Size, January 2018 to June 2023
Table 162: Top 10 Deals in the Market for Diabetes Therapeutics and Diagnostics, by Status, January 2018 to June 2023
Table 163: Global Market Share Analysis for Diabetes Therapeutics and Diagnostics, 2022
Table 164: Global Market Share Analysis for Diabetes Therapeutics, 2022
Table 165: Global Market Share Analysis for Diabetes Monitoring Devices and Accessories, 2022
Table 166: Global Market Share Analysis for Diabetes Delivery Devices, 2022
Table 167: Global Diabetes Diagnostics and Delivery Devices Market: Key Product Portfolio
Table 168: Abbott: Financials, 2016-2022
Table 169: Abbott: Product Portfolio, by Business Segment
Table 170: Abbott: Recent Developments, 2023
Table 171: AstraZeneca: Product Portfolio for Type 2 Diabetes Treatment
Table 172: AstraZeneca: Financial Performance, 2018-2022
Table 173: AstraZeneca: Selected Key Developments, 2023
Table 174: Braun: Products
Table 175: Braun: Financials, 2021
Table 176: Biocon: Product Portfolio for Type 2 Diabetes Treatment
Table 177: Biocon: Selected Key Developments, 2022
Table 178: Boehringer Ingelheim: Products Portfolio for Type 2 Diabetes Treatment
Table 179: Boehringer Ingelheim: Selected Key Developments, 2023
Table 180: Danaher Corp.: Product Portfolio
Table 181: Danaher Corp.: Financials, 2021
Table 182: Danaher Corp.: Products and Services
Table 183: Danaher Corp.: Recent Developments, 2023
Table 184: Dexcom: Financials, 2021 and 2022
Table 185: Insulet Corp.: Revenue, by Segment, 2020-2022
Table 186: Johnson & Johnson: Product Portfolio for Type 2 Diabetes Treatment
Table 187: Johnson & Johnson: Financials, 2021
Table 188: Johnson & Johnson: Product Portfolio
Table 189: Johnson & Johnson: Recent Developments and Strategies, 2017-2022
Table 190: Lilly: Product Portfolio for Type 2 Diabetes Treatment
Table 191: Lilly: Business Segments
Table 192: Lilly: Financial Performance, 2018-2021
Table 193: Lilly: Key Developments, 2023
Table 194: Medtronic: Financials, 2016-2022
Table 195: Medtronic: Product Portfolio
Table 196: Medtronic: Patient Monitoring Device Product Portfolio
Table 197: Medtronic: Recent Developments, 2015-2022
Table 198: Menarini Group: Key Financials, 2021
Table 199: Merck & Co. Inc.: Product Portfolio for Type 2 Diabetes Treatment
Table 200: Merck & Co. Inc.: Financial Performance, 2018-2022
Table 201: Merck KGaA: Key Financials, 2021
Table 202: Nipro Group: Financials, 2021
Table 203: Nipro Group: Product Portfolio, by Business Segment
Table 204: Nipro: Recent Developments, 2020
Table 205: Novartis: Product Portfolio for Type 2 Diabetes Treatment
Table 206: Novartis: Key Financials, 2021
Table 207: Novartis Key Developments, 2022
Table 208: Novo Nordisk: Product Portfolio for Type 2 Diabetes Treatment
Table 209: Novo Nordisk: Key Financials, 2021
Table 210: Novo Nordisk: Selected Key Developments, 2023
Table 211: Roche: Financials, 2021
Table 212: Roche: Revenue, by Business Segment, 2016-2021
Table 213: Roche: Revenue, by Diagnostic Segment, 2016-2021
Table 214: Roche: Product Portfolio
Table 215: Roche: Diagnostics Patient Monitoring Product Portfolio
Table 216: Roche: Recent Developments, 2023
Table 217: Sanofi: Product Portfolio for Type 2 Diabetes Treatment
Table 218: Sanofi: Business Segment
Table 219: Sanofi: Financial Performance, 2021 and 2022
Table 220: Sanofi: Key Developments, 2023
Table 221: Takeda: Key Financials, 2021
Table 222: Terumo Corp.: Financials, 2021
Table 223: Terumo Corp.: Recent Developments, 2020
Table 224: Government Regulatory Agencies and Professional Organizations
List of Figures
Summary Figure: Global Market for Diabetes Therapeutics and Diagnostics, by Segment, 2020-2028
Figure 1: Global Diabetes Incidence
Figure 2: Classification of Injectable Therapies for Diabetes
Figure 3: Classification of Oral Antidiabetic Drugs (OADs)
Figure 4: Global Initiatives Pertaining to Type 2 Diabetes
Figure 5: Type 2 Diabetes Agents in Clinical Development
Figure 6: Clinical Development Pipeline for Hanmi Pharma Co. Ltd.
Figure 7: Administration Route for Insulin Delivery
Figure 8: Schematic of a Closed-Loop Artificial Pancreas System
Figure 9: Schematic of the Edmonton Protocol
Figure 10: Product Pipeline Portfolio of Diabetology Ltd.
Figure 11: Global Market for Diabetes Therapeutics and Diagnostics, by Region
Figure 12: Global Market Shares of Diabetes Therapeutic and Diagnostics, by Region, 2022
Figure 13: Key Components of the German Statutory Health Insurance System, 2019
Figure 14: Risk of Developing Diabetes-Related Comorbidities
Figure 15: Global Market for Diabetes Therapeutics and Diagnostics Deal Activity, by Type, January 2018 to June 2023
Figure 16: Global Market for Diabetes Therapeutics and Diagnostics Deal Activity, by Top 10 Industries, January 2018 to June 2023
Figure 17: Global Market Share Analysis for Diabetes Therapeutics and Diagnostics, 2022
Figure 18: Global Market Share Analysis for Diabetes Therapeutics, 2022
Figure 19: Global Market Share Analysis for Diabetes Monitoring Devices and Accessories, 2022
Figure 20: Global Market Share Analysis for Diabetes Delivery Devices, 2022
Figure 21: Abbott: Revenue Share, by Country/Region, 2021 and 2022
Figure 22: Abbott: Revenue Share, by Business Segment, 2021 and 2022
Figure 23: Abbott: R&D Expenditures, 2015-2022
Figure 24: AstraZeneca: Sales Share, by Segment, 2022
Figure 25: AstraZeneca: Revenue Share, by Region, 2022
Figure 26: Braun: Revenue, 2015-2021
Figure 27: Braun: Revenue Share, by Country/Region, 2021
Figure 28: Braun: Revenue Share, by Segment, 2021
Figure 29: Boehringer Ingelheim: Annual Revenue, 2021 and 2022
Figure 30: Boehringer Ingelheim: Revenue Share, by Business Segment, 2021 and 2022
Figure 31: Boehringer Ingelheim: Revenue Share, by Region, 2021 and 2022
Figure 32: Danaher Corp.: Revenue Share, by Segment, 2021
Figure 33: Danaher Corp.: Revenue Share, by Country/Region, 2021
Figure 34: Dexcom Inc.: Annual Revenue, 2019-2021
Figure 35: Dexcom: Revenue Share, by Region, 2022
Figure 36: Dexcom: Revenue Share, by Sales Channel, 2022
Figure 37: Johnson & Johnson: Financials, 2017-2021
Figure 38: Johnson & Johnson: Revenue Share, by Country/Region, 2021
Figure 39: Johnson & Johnson: Revenue Share, by Segment, 2021
Figure 40: Lilly: Total Sales Share, by Product Segment, 2020
Figure 41: Lilly: Revenue Share, by Product, 2020
Figure 42: Medtronic: Financials, 2015-2022
Figure 43: Medtronic: Revenue Share, by Country/Region, 2022
Figure 44: Medtronic: Revenue Share, by Key Disease Segment, 2022
Figure 45: Menarini Group: Revenue Share, by Business Segment, 2021
Figure 46: Menarini Group: Total Revenue Share, by Region, 2021
Figure 47: Merck & Co. Inc.: Revenue Share, by Business Segment, 2022
Figure 48: Merck & Co. Inc.: Revenue Share, by Region, 2022
Figure 49: Merck KGaA: Revenue Share, by Business Segment, 2021
Figure 50: Merck KGaA: Total Revenue Share, by Region, 2021
Figure 51: Nipro Group: Revenue Share, by Country/Region, 2021
Figure 52: Nipro Group: Revenue Share, by Business Segment, 2021
Figure 53: Novartis: Revenue Share, by Business Segment, 2021
Figure 54: Novartis: Total Revenue Share, by Region, 2021
Figure 55: Novo Nordisk: Revenue Share, by Region, 2021
Figure 56: Novo Nordisk: Revenue Share, by Business Segment, 2021
Figure 57: Roche: Revenue Share, by Business Segment, 2021
Figure 58: Roche: Revenue Share, by Country/Region, 2021
Figure 59: Sanofi: Net Sales Share, by Business Segment, 2022
Figure 60: Sanofi: Net Sales Share, by Region, 2022
Figure 61: Takeda: Revenue Share, by Business Segment, 2021
Figure 62: Takeda Pharmaceutical: Total Revenue Share, by Region, 2021
Figure 63: Terumo Corp.: Revenue Share, by Segment, 2021
Figure 64: Terumo Corp.: Revenue Share, by Country/Region, 2021
